Contact
Please use this form to send email to PR contact of this press release:
Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia
TO:
Please use this form to send email to PR contact of this press release:
Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia
TO: